Three specific gut bacteria in the occurrence and development of colorectal cancer: a concerted effort

被引:7
|
作者
Gong, Dengmei [1 ]
Adomako-Bonsu, Amma G. [2 ]
Wang, Maijian [3 ]
Li, Jida [1 ]
机构
[1] Zunyi Med Univ, Coll Publ Hlth, Inst Zoonosis, Zunyi, Guizhou, Peoples R China
[2] Univ Med Sch Schleswig Holstein, Inst Toxicol & Pharmacol, Kiel, Germany
[3] Zunyi Med Univ, Affiliate Hosp, Gastrointestinal Surg, Zunyi, Guizhou, Peoples R China
来源
PEERJ | 2023年 / 11卷
关键词
Gut microbiota; Enterotoxigenic Bacteroides fragilis; Genotoxic Escherichia coli; Fusobacterium nucleatum; COLON-TUMOR GROWTH; GERM-FREE RATS; FUSOBACTERIUM-NUCLEATUM; MICROBIOTA; TOXIN; CARCINOGENESIS; CELLS; 1,2-DIMETHYLHYDRAZINE; INFLAMMATION; PROGRESSION;
D O I
10.7717/peerj.15777
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Colorectal cancer (CRC), which develops from the gradual evolution of tubular adenomas and serrated polyps in the colon and rectum, has a poor prognosis and a high mortality rate. In addition to genetics, lifestyle, and chronic diseases, intestinal integrity and microbiota (which facilitate digestion, metabolism, and immune regulation) could promote CRC development. For example, enterotoxigenic Bacteroides fragilis, genotoxic Escherichia coli (pks+ E. coli), and Fusobacterium nucleatum, members of the intestinal microbiota, are highly correlated in CRC. This review describes the roles and mechanisms of these three bacteria in CRC development. Their interaction during CRC initiation and progression has also been proposed. Our view is that in the precancerous stage of colorectal cancer, ETBF causes inflammation, leading to potential changes in intestinal ecology that may provide the basic conditions for pks+ E. coli colonization and induction of oncogenic mutations, when cancerous intestinal epithelial cells can further recruit F. nucleatum to colonise the lesion site and F. nucleatum may contribute to CRC advancement by primarily the development of cancer cells, stemization, and proliferation, which could create new and tailored preventive, screening and therapeutic interventions. However, there is the most dominant microbiota in each stage of CRC development, not neglecting the possibility that two or even all three bacteria could be engaged at any stage of the disease. The relationship between the associated gut microbiota and CRC development may provide important information for therapeutic strategies to assess the potential use of the associated gut microbiota in CRC studies, antibiotic therapy, and prevention strategies.
引用
收藏
页数:26
相关论文
共 50 条
  • [21] The Roles of Gut Microbiota Metabolites in the Occurrence and Development of Colorectal Cancer: Multiple Insights for Potential Clinical Applications
    Cheng, Wenyue
    Li, Fan
    Yang, Rongcun
    GASTRO HEP ADVANCES, 2024, 3 (06): : 855 - 870
  • [22] Gut vascular barrier impairment leads to intestinal bacteria dissemination and colorectal cancer metastasis to liver
    Bertocchi, Alice
    Carloni, Sara
    Ravenda, Paola Simona
    Bertalot, Giovanni
    Spadoni, Ilaria
    Lo Cascio, Antonino
    Gandini, Sara
    Lizier, Michela
    Braga, Daniele
    Asnicar, Francesco
    Segata, Nicola
    Klaver, Chris
    Brescia, Paola
    Rossi, Elio
    Anselmo, Achille
    Guglietta, Silvia
    Maroli, Annalisa
    Spaggiari, Paola
    Tarazona, Noelia
    Cervantes, Andres
    Marsoni, Silvia
    Lazzari, Luca
    Jodice, Maria Giovanna
    Luise, Chiara
    Erreni, Marco
    Pece, Salvatore
    Di Fiore, Pier Paolo
    Viale, Giuseppe
    Spinelli, Antonino
    Pozzi, Chiara
    Penna, Giuseppe
    Rescigno, Maria
    CANCER CELL, 2021, 39 (05) : 708 - +
  • [23] Co-occurrence of driver and passenger bacteria in human colorectal cancer
    Geng, Jiawei
    Song, Qingfang
    Tang, Xiaodan
    Liang, Xiao
    Fan, Hong
    Peng, Hailing
    Guo, Qiang
    Zhang, Zhigang
    GUT PATHOGENS, 2014, 6
  • [24] Determining the specific gut microbiota patterns associated with colorectal cancer
    Sahankumari, A. G. P.
    Gamage, B. D.
    Malavige, G. N.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 500 - 500
  • [25] Exploring the Role of the Gut Microbiota in Colorectal Cancer Development
    Ionescu, Vlad Alexandru
    Gheorghe, Gina
    Georgescu, Teodor Florin
    Buica, Vlad
    Catanescu, Mihai-Stefan
    Cercel, Iris-Andreea
    Budeanu, Beatrice
    Budan, Mihail
    Bacalbasa, Nicolae
    Diaconu, Camelia
    GASTROINTESTINAL DISORDERS, 2024, 6 (02): : 526 - 537
  • [26] Interplay between Dietary Polyphenols and Oral and Gut Microbiota in the Development of Colorectal Cancer
    Cueva, Carolina
    Silva, Mariana
    Pinillos, Iris
    Bartolome, Begona
    Victoria Moreno-Arribas, M.
    NUTRIENTS, 2020, 12 (03)
  • [27] Male-Biased Gut Microbiome and Metabolites Aggravate Colorectal Cancer Development
    Wang, Ling
    Tu, Yi-Xuan
    Chen, Lu
    Zhang, Yuan
    Pan, Xue-Ling
    Yang, Shu-Qiao
    Zhang, Shuai-Jie
    Li, Sheng-Hui
    Yu, Ke-Chun
    Song, Shuo
    Xu, Hong-Li
    Yin, Zhu-Cheng
    Yue, Jun-Qiu
    Ni, Qian-Lin
    Tang, Tang
    Zhang, Jiu-Liang
    Guo, Min
    Zhang, Shuai
    Yao, Fan
    Liang, Xin-Jun
    Chen, Zhen-Xia
    ADVANCED SCIENCE, 2023, 10 (25)
  • [28] Growth rate alterations of human colorectal cancer cells by 157 gut bacteria
    Taddese, Rahwa
    Garza, Daniel R.
    Ruiter, Lilian N.
    de Jonge, Marien, I
    Belzer, Clara
    Aalvink, Steven
    Nagtegaal, Iris D.
    Dutilh, Bas E.
    Boleij, Annemarie
    GUT MICROBES, 2020, 12 (01) : 1 - 20
  • [29] Prediction model of poorly differentiated colorectal cancer (CRC) based on gut bacteria
    Qi, Zhang
    Zuo, Zhibo
    Jing, Zhuang
    Qu, Zhanbo
    Han, Shugao
    Jin, Weili
    Jiang, Liu
    Han, Shuwen
    BMC MICROBIOLOGY, 2022, 22 (01)
  • [30] The role of gut microbiota and drug interactions in the development of colorectal cancer
    Wu, Jinna
    Xia, Cong
    Liu, Can
    Zhang, Qianshi
    Xia, Chenglai
    FRONTIERS IN PHARMACOLOGY, 2023, 14